GeneCast Biotechnology Overview

  • Founded
  • 2014
  • Status
  • Private
  • Latest Deal Type
  • Series E
  • Latest Deal Amount
  • $148M
Latest Deal Amount
  • Investors
  • 17

GeneCast Biotechnology General Information


Developer of a cancer diagnosis and therapeutics solutions platform intended to detect tumors and cancer-causing genes in blood. The company's provides non-invasive and precise diagnosis of tumors as well as personalized cancer treatment based on high throughput sequencing, bioinformatics and cutting-edge translational medicine enabling guidance in personalized medicine to prolong patient's life span and improve their quality of life. The company is specialized in diagnosing lung cancer, colon cancer, liver cancer and breast cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • Block D, Xidong Chuangrong Building
  • No. 88 Danshan Road, Anzhen Street, Xishan District
  • Wuxi, Jiangsu
  • China
+86 400 000 0000

GeneCast Biotechnology Timeline

Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GeneCast Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series E) 26-Oct-2020 $148M 00000 Completed Generating Revenue
6. Later Stage VC (Series D) 30-Oct-2019 000.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series C) 01-Jan-2018 00.000 00000 Completed Generating Revenue
4. Early Stage VC (Series B) 01-Jan-2017 00.000 000.00 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series A) 29-Jan-2016 00.000 00.000 000.00 Completed Startup
2. Secondary Transaction - Private 28-Dec-2016 $400K Completed Startup
1. Seed Round 28-Feb-2015 $400K $400K 000 Completed Startup
To view GeneCast Biotechnology’s complete valuation and funding history, request access »

GeneCast Biotechnology Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of a cancer diagnosis and therapeutics solutions platform intended to detect tumors and cancer-causing genes i
Wuxi, China
00000000000 00000


e irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excep
0000000000 000000000
Pittsburgh, PA
00 As of 0000
0.00 0000-00-00
00000000000 00.00

00000 00

co laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupt
Aliso Viejo, CA
000 As of 0000
00 0000-00-00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GeneCast Biotechnology Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cernostics Venture Capital-Backed Pittsburgh, PA 00 00.00 00000000000 00.00
00000 00000000 Private Equity-Backed Aliso Viejo, CA 000 000000&0
000000000 00000 Venture Capital-Backed Siena, Italy 00 0000000000 0
00000000 Venture Capital-Backed Seattle, WA 00 0000 000000000 - 0000
000000 000000 Venture Capital-Backed South Plainfield, NJ 00 000000000 -
You’re viewing 5 of 29 competitors. Get the full list »

GeneCast Biotechnology Executive Team (5)

Name Title Board Seat Contact Info
Bo Du Ph.D Co-Founder & Chief Executive Officer
Haibo Wang Chief Technology Officer
Henghui Zhang MD Co-Founder & Chief Scientific & Medical Officer
Xiao Li Director of Finance
Guosheng Ma Vice President & Co-Founder
To view GeneCast Biotechnology’s complete executive team members history, request access »

GeneCast Biotechnology Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
China Renaissance Investment Bank Minority 000 0000 000000 0
China Structural Reform Fund Corporation Minority 000 0000 000000 0
Hillhouse Capital Group PE/Buyout Minority 000 0000 000000 0
Shanghai Jianxin Capital Venture Capital Minority 000 0000 000000 0
Skycus Capital Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »